MaxCyte, Inc. (MXCT) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc. (NASDAQ: MXCT) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $9 million versus the consensus estimate of $10.65 million.
For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Movano (MOVE) Misses Q2 EPS by 195c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
